CUSIP 95075A107COMHOWLQ4 2025
34 filings · latest Feb 11, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 6.68M | $4.23M |
| 2 | Vanguard Group Inc | 1.41M | $892.7K |
| 3 | Mpm Bioimpact LLC | 1.39M | $883.5K |
| 4 | Bank Of America Corp /De/ | 737.5K | $466.9K |
| 5 | Renaissance Technologies LLC | 677.8K | $429.4K |
| 6 | Lynx1 Capital Management LP | 655.9K | $415.5K |
| 7 | Sphera Funds Management Ltd. | 626.8K | $397.1K |
| 8 | Dc Funds, LP | 589.1K | $373.2K |
| 9 |
| 4 | Dec 3, 2025 | Mpm Bioventures 2014, L.P. | 13D/A | 10.0% | — | SEC |
| 5 | Nov 17, 2025 | Mpm Bioventures 2014, L.P. | 13D/A | 11.3% | — | SEC |
| 6 | Nov 6, 2025 | Ra Capital Management, L.P. | 13D/A | 13.8% | — | SEC |
| 7 | Nov 4, 2025 | Mpm Bioventures 2014, L.P. | 13D/A | 13.4% | — | SEC |
| 8 | Aug 14, 2025 | Pfm Health Sciences, LP | 13G/A | 0.9% | 401.1K | SEC |
| 9 | May 14, 2025 | Ra Capital Management, L.P. | 13D/A | 15.0% | — | SEC |
| 10 | Feb 14, 2025 | Pfm Health Sciences, LP | 13G/A | 6.5% | 2.91M | SEC |
See the full Schedule 13D/13G history for Werewolf Therapeutics Inc.
Unlock full history| Geode Capital Management, LLC |
| 335.9K |
| $212.8K |
| 10 | Millennium Management LLC | 240.1K | $152.1K |